Home/Filings/4/0000950170-23-044403
4//SEC Filing

Svoronos Dawn 4

Accession 0000950170-23-044403

CIK 0001582313other

Filed

Aug 23, 8:00 PM ET

Accepted

Aug 24, 4:33 PM ET

Size

4.9 KB

Accession

0000950170-23-044403

Insider Transaction Report

Form 4
Period: 2023-08-24
Graham Dawn
Director
Transactions
  • Sale

    Common Shares

    2023-08-24$38.70/sh25,000$967,50025,000 total
Footnotes (1)
  • [F1]The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $38.70 to $38.79, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.

Documents

1 file

Issuer

Xenon Pharmaceuticals Inc.

CIK 0001582313

Entity typeother

Related Parties

1
  • filerCIK 0001574579

Filing Metadata

Form type
4
Filed
Aug 23, 8:00 PM ET
Accepted
Aug 24, 4:33 PM ET
Size
4.9 KB